Dexamethasone suppression test protocol

• Patients can eat and drink normally and take all their usual medications prior to the test. Estrogen containing medications, including the contraceptive pill and hormone replacement therapy, should be stopped for six weeks prior to measuring serum cortisol. This is because estrogen induces cortisol binding globulin and leads to elevations in measured serum cortisol. Any steroid containing medications should also be documented, and avoided if possible, as they may interfere with the hypothalamo-pituitary-adrenal axis or cross-react with the cortisol assay.

• Care is needed in patients with suspected or active peptic ulcer disease (referring physician may prescribe proton pump inhibitor prior to test). Care is also needed in patients with diabetes mellitus, as blood sugars may rise during test. Referring clinician will advise patient whether they need to increase dose of insulin, or just test blood glucose more frequently during test.

• Potent inducers of the cytochrome P450 system accelerate the clearance of dexamethasone and so invalidate this test. Patients taking rifampicin, phenytoin, phenobarbitone and carbamezepine should therefore be discussed with the endocrinologist, before proceeding with the test as interpretation will be difficult.

Please note: If the patient is collecting a 24 h urine sample for urinary free cortisol this should be done BEFORE taking the dexamethasone.

Overnight low-dose suppression test

• 1mg dexamethasone is administered to the patient to be taken at home at 10pm. The patient is then advised to return for a blood test (plain clotted tube only for cortisol) at 9am the following morning. The tube must be clearly labelled as: post-1mg dexamethasone.

Low-dose suppression test (48hrs)

• Day 1: 9am baseline blood test taken into a plain clotted tube for cortisol. In patients with virilisation, the blood will also be tested for other adrenal steroids: testosterone, dehydroepiandrosterone (DHEAS,) 17-hydroxyprogesterone and androstenedione as specified by the requesting clinician. The bottle and request form should be labelled “2+0” (2mg total dose over 24hrs, time=0.)

• The patient then takes their first dexamethasone tablet at 9am. The patient is given 9 tablets of 0.5mg dexamethasone altogether which includes this first supervised dose and one spare tablet in case of mishap. The patient then takes the following tablets strictly eight hourly for the next 48 hours: at 3pm, 9pm, 3am and 9am.

• Day 3: 9am, patient returns for the second blood test labelled “2+48” having taken their last dose of dexamethasone at 3am that morning. In patients admitted to hospital, an extra blood test is taken at 24 hours, at 9am on day 2, prior to their fifth dose of dexamethasone and labelled “2+24.”

High-dose suppression test

• The procedure for the high dose dexamethasone suppression test is identical to that for the low dose dexamethasone suppression test, except that each dose is 2mg rather than 0.5mg dexamethasone. Samples are labelled “8+0,” “8+24,” and “8+48” for 8mg total daily dose, at times: 0, 24 and 48 hours. Since this test requires the patient to take high doses of steroids which may cause more severe side effects, this is usually supervised during a hospital admission.

Submitting samples to laboratory

• Dexamethasone challenge samples must be clearly labelled with date and time of collection and ALL samples submitted TOGETHER to Clinical Biochemistry staff - if these are separated this may result in diagnostic delays and/or disconnected/ non-interpretable order sets

Expected results

A normal response is demonstrated by suppression of 09:00 cortisol <50 nmol/L. (Please note: as cortisol falls after 9am there is a potential for false positives should sampling be delayed.)

References

This investigation is taken from "Endobible: Practical guidance on endocrine diagnosis and management," K. Meeran et al. (http://www.endobible.com/investigation/dexamethasone-suppression-test/)